Fermer le menu


Member of Lyonbiopole


DicarTech is developing an innovative non-invasive diagnostic medical device for intensive care, pediatry, emergency physicians. DiCART measures the tissue perfusion for patients in severe circulatory failure. Critical situation which, without treatment, can lead to multi-organ failure, lethal situation. DiCART enables reliable, accurate rapid diagnosis to objectively appreciate the efficiency of the therapies involved. Replaces manual and visual assessments, imprecise.

The measure is based on Capillary Refill Time.

A clinical trial on patients has started 09/2022 in Lyon.

Time to market within 9 months.


Strategic application domain: Human Medicine

Application market: Cardiology, Intensive care medicine

Type of activity: Medical device

Technologies: ICT for Health - Digital, Surgical & Medical instruments

Created on jan. 30th, 2018 - 5 employees



28 chem des Pilles 07100 Annonay



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.